Letter outlines Phase 3 timeline for PrimeC in ALS, provides update on Canadian regulatory pathway and strategic partnership discussions; Company optimistic about ongoing ...

Alzinova AB (publ) (ticker: ALZ) is pleased to announce the release of the drug substance for its upcoming Phase 2 clinical trial of the vaccine candidate ALZ-101 in early Alzheimer's disease. This mi ...

We published the book "Demystifying Psychiatry" in 2010. Although basic principles of psychiatric treatment remain unchanged, ...

Between 2021 and 2024, the share of spine surgeries performed in the ASC setting has grown 8% year over year nationwide, but one ASC is doubling that volume. Gautier, Miss.-based Bienville Orthopaedic ...

The medical imaging industry is a somewhat consolidated oligopoly, with the top three players GEHC, Siemens Healthineers, and Philips controlling about 70% of the market. They largely compete by ...

Arcellx Inc. company and executive profile by Barron's. View the latest ACLX company infomation and executive bios.

Child diagnoses are rising; however, due to changing definitions, systems, and expectations, it is not an epidemic of illness ...

Startup Brellium built an artificial-intelligence-powered solution that helps providers automate clinical quality and payer ...

AbbVie is a popular stock with dividend investors for its high starting yield and continuous dividend increases. AbbVie is a ...

Iovance Biotherapeutics (NASDAQ: IOVA) is one such company right now, entering a decade of incredible growth. Here's why ...

BayCare Health System recently finalized its $4 billion disaffiliation from Trinity Health, ushering in what executives are calling “BayCare 2.0” — a new era of local governance, strategic agility and ...